AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

B-Cell Malignancy, Low-Grade

1
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT01618136
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors
Completed · Phase 1|Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for B-Cell Malignancy, Low-Grade
🏥 Names
Disease Name
B-Cell Malignancy, Low-Grade
Alias Names
Chronic Lymphocytic Leukemia; Leukemia, Chronic Lymphocytic, Susceptibility To, 2; B-Cell Malignancy, Low-Grade
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
Disease Ontology
1040
DisGeNET
C1868683
🔍 Raw view — every non-empty column on this row (24 fields)
name
B-Cell Malignancy, Low-Grade
alias name
Chronic Lymphocytic Leukemia; Leukemia, Chronic Lymphocytic, Susceptibility To, 2; B-Cell Malignancy, Low-Grade
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS018473
disgenet id
C1868683
do id
1040
omim id
109543

⚗️ Related Ingredients

1 · compounds in this herb

📋 Clinical Trials

1 · subject of clinical study
NCT01618136 An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP
→ Malignant Solid Tumour|Ovarian Cancer|Triple Negat
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables